Xencor Inc (XNCR) Stock Analysis
Verdict: WATCH (do not buy)
A $599.8M liquid current asset buffer gives XNCR 3+ years of clinical runway, but a -155.6% net margin requires Phase 2 oncology catalyst validation.
Investment score: 53/100
Analysis as of
Is Xencor Inc stock worth reviewing? The TradeMates thesis
Xencor presents a strong liquidity backstop with $599.8M in current assets against -$138.3M FCF burn, but clinical binary risk and negative profitability (-155.6% net margin) warrant a neutral Hold rating at $24.57.
7-factor investment score
- Valuation: 40/100 (weight 20%)
- Financial Health: 50/100 (weight 15%)
- Technical Momentum: 70/100 (weight 15%)
- Earnings Quality: 60/100 (weight 15%)
- Insider Sentiment: 35/100 (weight 10%)
- Analyst Consensus: 75/100 (weight 10%)
- Risk-Adjusted Return: 45/100 (weight 15%)
Xencor Inc opportunities and risks
What speaks for XNCR
- Multi-Year Liquidity Runway
What speaks against XNCR
- Severe Operational Cash Losses and High P/S Valuation
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| XNCR | n/a | 17.3x | n/a | 43.3% | -155.6% | -11.4% |
| KLRA | n/a | 0.0x | n/a | 0.0% | 0.0% | -8.7% |
| ANAB | n/a | 7.0x | 28.3x | 116.4% | -11.5% | 0.3% |
| ZYME | n/a | 54.6x | n/a | 87.8% | -404.0% | -5.9% |
| NVAX | n/a | 4.1x | n/a | 77.9% | -59.9% | -2.6% |
| SNDX | n/a | 6.3x | n/a | 97.5% | -87.6% | -13.9% |
| Peer median | n/a | 6.3x | n/a | 87.8% | -59.9% | -5.9% |
Frequently asked questions about Xencor Inc (XNCR)
Is XNCR stock a good investment?
The TradeMates model rates Xencor Inc as WATCH (do not buy) with an investment score of 53/100. Xencor presents a strong liquidity backstop with $599.8M in current assets against -$138.3M FCF burn, but clinical binary risk and negative profitability (-155.6% net margin) warrant a neutral Hold rating at $24.57. This is algorithmic model output, not personal investment advice.
Is XNCR stock a buy?
The TradeMates model verdict for XNCR is WATCH (do not buy) with an investment score of 53/100. Treat this as a model signal to review, not a personal buy recommendation.